Amlin Plc
CONFIRMATION OF REGULATORY UNDERWRITING CAPACITY
Amlin plc ('Amlin') confirms that Syndicate 2001's regulatory underwriting
capacity for 2004 is being maintained at its 2003 level of £1 billion. Amlin
owns 100% of its managed Syndicate 2001 for the 2004 year of account. This
equates to 16% growth in Amlin's owned underwriting capacity from 2003.
Amlin's capacity for 2004 is supported through its own resources, by letters of
credit totalling £130 million from a syndicate of banks led by Lloyds TSB Bank
plc (2003: £70 million) and by letters of credit totalling US$90 million
provided through Amlin's 12.7% shareholder, State Farm Mutual Automobile
Insurance Company (2003: US$130 million).
17 December 2003
Enquiries:
Richard Hextall 020 7746 1000
Finance Director, Amlin plc
Explanatory note:
Lloyd's regulatory capacity is a ceiling on premium income, net of brokerage,
related to a group's Funds at Lloyd's at the start of the year. Premium income
during the year may or may not reach such levels.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.